Sheree H. Cheung

Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma

Jeffrey S. Morris, Manal M. Hassan, James C Yao, 2016, OncoTargets and therapy.

Deployment of an Interventional Radiology Telemedicine Program During the COVID-19 Pandemic: Initial Experience With 10,056 Visits

Sanjay Gupta, R. Sheth, Steven Y. Huang, 2021, Journal of the American College of Radiology.

Development and Validation of Insulin-like Growth Factor-1 Score to Assess Hepatic Reserve in Hepatocellular Carcinoma

Jeffrey S. Morris, Manal M. Hassan, S. Curley, 2014, Journal of the National Cancer Institute.

Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma

Manal M. Hassan, M. Wallace, R. Murthy, 2016, Journal of hepatocellular carcinoma.

Phase ii trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma

Manal M. Hassan, R. Wolff, Lianchun Xiao, 2016 .

Validation of an IGF-CTP scoring system for assessing hepatic reserve in egyptian patients with hepatocellular carcinoma

Jeffrey S. Morris, Manal M. Hassan, Ju-Seog Lee, 2015, Oncotarget.

Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma

R. Murthy, A. Kaseb, K. Raghav, 2016, Journal of hepatocellular carcinoma.